Centers for Disease Control and Prevention (CDC) has updated its recommendations for people who are at higher risk for complications from COVID-19 -- including people over 60 and those with severe chronic medical conditions -- to "stay at home as much as possible" and "avoid crowds." According to the CDC website, "Older adults and people who have severe chronic medical conditions like heart, lung or kidney disease seem to be at higher risk for more serious COVID-19 illness. We asked Michael George, MD, a rheumatologist and epidemiologist who studies infections in patients with autoimmune disease, who should follow this new guidance. “The more at risk you are, the more you should consider this recommendation.” He says this new guidance particularly applies to those with more severe disease or who have been hospitalized in the past with a respiratory infection or have interstitial lung disease, COPD or asthma, for example. Prophylaxis for chloroquine resistant malaria Patient teaching when taking hydroxychloroquine Plaquenil Use in Autoimmune Diseases by Dermatologists and Rheumatologists Dr. Camisa February 9, 2014 February 9, 2014 Autoimmune diseases / Lupus / Psoriasis / Treatments It may surprise you to learn that anti-malarial drugs are used by dermatologists and rheumatologists. Undifferentiated connective tissue disease UCTD is an autoimmune disease that can affect several systems in the body. Connective tissue disease CTD is classified as undifferentiated CTD when signs and symptoms are consistent with a CTD, but do not fulfill the diagnostic or classification criteria for one of the previously defined CTDs for example, rheumatoid arthritis or lupus. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. (See below for more details on risk factors.) People with osteoarthritis, or non-autoimmune types of arthritis, who have risk factors, such as age (over 60 years) or severe underlying medical condition should follow the CDC guidance on crowd avoidance, too. George adds, “everyone should follow the general precautions,” such as handwashing, not touching your face, eyes, nose or mouth. Those with more mild disease may want to ask their doctor for guidance. How does plaquenil help autoimmune diseases Plaquenil a possible treatment for coronavirus? lupus, Undifferentiated connective tissue disease Genetic and Rare Diseases. Chloroquine drug resistanceChloroquine phosphate fish dosage Approved for lupus by the Food and Drug Administration FDA in the 1950s, recent research suggests that Plaquenil may help lower the risk of a blood clot in people who have lupus and antiphospholipid antibodies. Antiphospholipid Syndrome Evaluating current treatment options Lupus.. Hydroxychloroquine Plaquenil. Coronavirus and Arthritis What You Need to Know.. Aug 27, 2014 Cookiiez95 - I tried plaquenil for 6 months on top of methotrexate rheumatoid arthritis + other autoimmune diagnoses and saw no benefit, but don't recall having negative side effects, either. It also failed to help my mom, who was on it for years, despite its failure to help. Plaquenil is a DMARD which has been prescribed for years to treat rheumatoid arthritis, lupus, juvenile rheumatoid arthritis, and other autoimmune diseases. When the first biologic DMARD received FDA-approval in 1998, and as other biologics followed in subsequent years, it appeared as though Plaquenil would become less prescribed. Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except.